What does DUPUIS-CHARPENTIER MEDICAL do?

DUPUIS-CHARPENTIER MEDICAL is a specialist medical practice in Libramont-Chevigny. Private Limited, started on 26 November 2019, 1 establishment.

What is the address of DUPUIS-CHARPENTIER MEDICAL?

The registered office of DUPUIS-CHARPENTIER MEDICAL is located at Ourt,Fond Djèvrê 54, 6800 Libramont-Chevigny.

Is DUPUIS-CHARPENTIER MEDICAL still active?

Yes. According to the CBE (28 September 2026) DUPUIS-CHARPENTIER MEDICAL is active, legal situation “Normale toestand”, started on 26 November 2019.

Is DUPUIS-CHARPENTIER MEDICAL registered on Peppol?

Yes, DUPUIS-CHARPENTIER MEDICAL is registered on the Peppol network with ID 0208:0738424673.

What is the enterprise number of DUPUIS-CHARPENTIER MEDICAL?

The enterprise number of DUPUIS-CHARPENTIER MEDICAL is BE0738424673.

When was DUPUIS-CHARPENTIER MEDICAL founded?

DUPUIS-CHARPENTIER MEDICAL was founded on 26 November 2019.

Who are the directors of DUPUIS-CHARPENTIER MEDICAL?

According to the 2025 annual accounts, the directors of DUPUIS-CHARPENTIER MEDICAL are: Pascaline CHARPENTIER, Fabien DUPUIS.

Is DUPUIS-CHARPENTIER MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 November 2019; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DUPUIS-CHARPENTIER MEDICAL make in 2025?

DUPUIS-CHARPENTIER MEDICAL posted a profit after taxes of € 229,039 in financial year 2025.

What is the revenue of DUPUIS-CHARPENTIER MEDICAL?

As a small company, DUPUIS-CHARPENTIER MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 321,550.

DUPUIS-CHARPENTIER MEDICAL (Private Limited)

Dossier DUPUIS-CHARPENTIER MEDICAL, printed on 28 September 2026 from databakkes.be/en/0738424673/dupuis-charpentier-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DUPUIS-CHARPENTIER MEDICAL from Libramont-Chevigny, company number BE0738424673, closed financial year 2025 with a result of € 229,039 after tax. For that financial year DUPUIS-CHARPENTIER MEDICAL recorded a gross margin of € 321,550 and equity of € 431,466. Compared with financial year 2024, the result moved from € 192,287 to € 229,039. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 431,466

▲ 39% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 229,039

▲ 19% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 102,414

▼ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 109,000 paid out

48 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 27,724

▼ 18% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,833

▲ € 1,465 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 35,672

▼ 4% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 131,164 Gross margin 2022: € 131,164 First fiscal year in the series	€ 231,341 Gross margin 2023: € 231,341 ▲ 76% vs 2022 (€ 131,164) Favourable step	€ 273,311 Gross margin 2024: € 273,311 ▲ 18% vs 2023 (€ 231,341) Favourable step	€ 321,550 Gross margin 2025: € 321,550 ▲ 18% vs 2024 (€ 273,311) Favourable step	▲ 18%
Profit after taxes	€ 92,219 Profit after taxes 2022: € 92,219 First fiscal year in the series	€ 165,052 Profit after taxes 2023: € 165,052 ▲ 79% vs 2022 (€ 92,219) Favourable step	€ 192,287 Profit after taxes 2024: € 192,287 ▲ 17% vs 2023 (€ 165,052) Favourable step	€ 229,039 Profit after taxes 2025: € 229,039 ▲ 19% vs 2024 (€ 192,287) Favourable step	▲ 19%
Equity	€ 154,088 Equity 2022: € 154,088 First fiscal year in the series	€ 219,140 Equity 2023: € 219,140 ▲ 42% vs 2022 (€ 154,088) Favourable step	€ 311,427 Equity 2024: € 311,427 ▲ 42% vs 2023 (€ 219,140) Favourable step	€ 431,466 Equity 2025: € 431,466 ▲ 39% vs 2024 (€ 311,427) Favourable step	▲ 39%
Total debts	€ 69,636 Total debts 2022: € 69,636 First fiscal year in the series	€ 152,193 Total debts 2023: € 152,193 ▲ 119% vs 2022 (€ 69,636) Unfavourable step	€ 128,030 Total debts 2024: € 128,030 ▼ 16% vs 2023 (€ 152,193) Favourable step	€ 124,195 Total debts 2025: € 124,195 ▼ 3% vs 2024 (€ 128,030) Favourable step	▼ 3%
Cash	€ 163,970 Cash 2022: € 163,970 First fiscal year in the series	€ 73,868 Cash 2023: € 73,868 ▼ 55% vs 2022 (€ 163,970) Unfavourable step	€ 149,505 Cash 2024: € 149,505 ▲ 102% vs 2023 (€ 73,868) Favourable step	€ 102,414 Cash 2025: € 102,414 ▼ 31% vs 2024 (€ 149,505) Unfavourable step	▼ 31%
Retained profit	€ 150,088 Retained profit 2022: € 150,088 First fiscal year in the series	€ 215,140 Retained profit 2023: € 215,140 ▲ 43% vs 2022 (€ 150,088) Favourable step	€ 307,427 Retained profit 2024: € 307,427 ▲ 43% vs 2023 (€ 215,140) Favourable step	€ 427,466 Retained profit 2025: € 427,466 ▲ 39% vs 2024 (€ 307,427) Favourable step	▲ 39%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 Unchanged (€ 0) Unchanged	€ 100,000 Dividend 2024: € 100,000 Unchanged (€ 100,000) Unchanged	€ 109,000 Dividend 2025: € 109,000 ▲ 9% vs 2024 (€ 100,000) Unchanged	▲ 9%
Balance sheet total	€ 223,724 Balance sheet total 2022: € 223,724 First fiscal year in the series	€ 371,333 Balance sheet total 2023: € 371,333 ▲ 66% vs 2022 (€ 223,724) Unchanged	€ 439,457 Balance sheet total 2024: € 439,457 ▲ 18% vs 2023 (€ 371,333) Unchanged	€ 555,661 Balance sheet total 2025: € 555,661 ▲ 26% vs 2024 (€ 439,457) Unchanged	▲ 26%

Key figures of DUPUIS-CHARPENTIER MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DUPUIS-CHARPENTIER MEDICAL?

What happened at DUPUIS-CHARPENTIER MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 229,039 (▲ 19% vs 2024). Source: NBB ↗
Nov 26, 2019 New establishment in Libramont-Chevigny. KBO
Nov 26, 2019 Start of the company according to the CBE. KBO
2019 Pascaline CHARPENTIER became a director. NBB
2019 Fabien DUPUIS became a director. NBB

In short

From € 92,219 profit in 2022 to € 229,039 profit in 2025.

Paid € 262,625 in corporate taxes since 2022.

Best year ever: 2025, with € 229,039 profit.

Paid out € 309,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DUPUIS-CHARPENTIER MEDICAL? We notify you, reason included.

Follow DUPUIS-CHARPENTIER MEDICAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Pascaline CHARPENTIER Fabien DUPUIS

DUPUIS-CHARPENTIER MEDICAL

Behind DUPUIS-CHARPENTIER MEDICAL are Pascaline CHARPENTIER and Fabien DUPUIS.

See the full network in the app

Directors

According to the 2025 annual accounts

Pascaline CHARPENTIER

Director

since 2019

Fabien DUPUIS

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Ourt,Fond Djèvrê 54

6800 Libramont-Chevigny

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0738.424.673
VAT number: BE 0738.424.673
Registered office: Ourt,Fond Djèvrê 54, 6800 Libramont-Chevigny
Names & denominations: DUPUIS-CHARPENTIER MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 November 2019
Peppol: Active · Active since 29 Oct 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗